SYSTEMIC AND CORONARY HEMODYNAMICS AND PHARMACODYNAMICS OF ENALAPRIL AND ENALAPRILAT IN CONGESTIVE HEART-FAILURE

被引：6
|
作者：
CHATTERJEE, K
DEMARCO, T
机构：
[1] Division of Cardiology, University of California, San Francisco, California
来源：
DRUGS | 1990年 / 39卷
关键词：
D O I：
10.2165/00003495-199000394-00007
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
Enalapril is an effective angiotensin-converting enzyme (ACE) inhibitor which produces salutary, beneficial haemodynamic effects in patients with congestive heart failure. Enalapril also produces beneficial neurohumoral changes, as well as improving abnormal coronary haemodynamics and myocardial energetics that are frequently encountered in these patients. Administration of enalapril once or twice daily appears to be quite effective during maintenance therapy in patients with chronic congestive heart failure. © 1990, ADIS Press Limited. All rights reserved.
引用
收藏
页码：29 / 40
页数：12
相关论文
共 50 条
  • [1] ENALAPRIL FOR CONGESTIVE HEART-FAILURE
    KJEKSHUS, J
    SWEDBERG, K
    AMERICAN JOURNAL OF CARDIOLOGY, 1989, 63 (08): : D26 - D32
  • [2] PHARMACOKINETICS AND PHARMACODYNAMICS OF ENALAPRIL IN PATIENTS WITH CONGESTIVE HEART-FAILURE AND PATIENTS WITH HYPERTENSION
    SCHWARTZ, JB
    TAYLOR, A
    ABERNETHY, D
    OMEARA, M
    FARMER, J
    YOUNG, J
    NELSON, E
    POOL, J
    MITCHELL, JR
    JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 1985, 7 (04) : 767 - 776
  • [3] THE EFFECT OF NITROPRUSSIDE ON CORONARY AND SYSTEMIC HEMODYNAMICS IN PATIENTS WITH SEVERE CONGESTIVE HEART-FAILURE
    POWERS, ER
    REISON, DS
    BERKE, A
    WEISS, MB
    CANNON, PJ
    CIRCULATION, 1982, 66 (04) : 211 - 211
  • [4] EFFECT OF HYDRALAZINE ON CORONARY HEMODYNAMICS IN CONGESTIVE HEART-FAILURE
    MAGORIEN, RD
    BROWN, G
    UNVERFERTH, DV
    BOUDOULAS, H
    BAMBACH, D
    LEIER, CV
    CLINICAL RESEARCH, 1980, 28 (04): : A713 - A713
  • [5] TOLERABILITY OF ENALAPRIL IN CONGESTIVE HEART-FAILURE
    KJEKSHUS, J
    SWEDBERG, K
    AMERICAN JOURNAL OF CARDIOLOGY, 1988, 62 (02): : A67 - A72
  • [6] TOLERABILITY OF ENALAPRIL IN CONGESTIVE HEART-FAILURE
    WARNER, NJ
    RUSH, JE
    KEEGAN, ME
    AMERICAN JOURNAL OF CARDIOLOGY, 1989, 63 (08): : D33 - D37
  • [7] ENALAPRIL IN THE TREATMENT OF CONGESTIVE HEART-FAILURE
    GILES, T
    JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 1990, 15 : S6 - S10
  • [8] THE EFFECT OF CAPTOPRIL ON RENAL, CORONARY, AND SYSTEMIC HEMODYNAMICS IN PATIENTS WITH SEVERE CONGESTIVE HEART-FAILURE
    POWERS, ER
    BANNERMAN, KS
    STONE, J
    REISON, DS
    ESCALA, EL
    KALISCHER, A
    WEISS, MB
    SCIACCA, RR
    CANNON, PJ
    AMERICAN HEART JOURNAL, 1982, 104 (05) : 1203 - 1210
  • [9] ALTERED PHARMACOKINETICS AND PHARMACODYNAMICS OF ENALAPRIL IN PATIENTS WITH CONGESTIVE HEART-FAILURE VERSUS PATIENTS WITH HYPERTENSION
    SCHWARTZ, JB
    TAYLOR, AA
    ABERNETHY, DR
    OMEARA, ME
    FARMER, JA
    YOUNG, JB
    NELSON, EB
    POOL, JL
    MITCHELL, JR
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1985, 5 (02) : 544 - 544
  • [10] THE EFFECT OF CAPTOPRIL ON SYSTEMIC AND RENAL HEMODYNAMICS IN PATIENTS WITH CONGESTIVE HEART-FAILURE
    POWERS, ER
    STONE, JE
    BANNERMAN, KS
    REISON, DS
    WEISS, MB
    SCIACCA, RR
    CANNON, PJ
    AMERICAN JOURNAL OF CARDIOLOGY, 1982, 49 (04): : 925 - 925
12345